Shichun Lu

机构：Zunyi Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Academy of Military Medical Sciences, Chinese PLA General Hospital, First People’s Hospital of Zunyi, The 309th Hospital of Chinese People's Liberation Army · ORCID：0000-0002-6974-4695

发表论文 33 篇 · 总被引 392 次 · h-index 11

代表论文

• Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancer (2025 · Cancer Cell · 被引 76)
• Prognostic role of tumor mutation burden in hepatocellular carcinoma after radical hepatectomy (2020 · Journal of Surgical Oncology · 被引 58)
• A Single-Cell Atlas of the Multicellular Ecosystem of Primary and Metastatic Hepatocellular Carcinoma (2020 · SSRN Electronic Journal · 被引 34)
• PLK1/NF-κB feedforward circuit antagonizes the mono-ADP-ribosyltransferase activity of PARP10 and facilitates HCC progression (2020 · Oncogene · 被引 31)
• Analysis of Sonazoid contrast-enhanced ultrasound for predicting the risk of microvascular invasion in hepatocellular carcinoma: a prospective multicenter study (2023 · European Radiology · 被引 21)
• Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition) (2024 · BioScience Trends · 被引 20)